Laboratory Corporation of Amerc Holdings (N:LH)

Business Focus: Healthcare Facilities & Services

Apr 29, 2024 07:00 am ET
Apr 25, 2024 06:58 am ET
Apr 24, 2024 09:27 pm ET
Labcorp Announces Winning Bid for Select Assets of Invitae
Advances Labcorp strategy to launch and scale specialty testing in areas such as oncology and rare diseases
Apr 24, 2024 09:19 pm ET
Invitae Enters into Agreement with Labcorp for Sale of Business
– Labcorp Selected as Winning Bidder in Court-Supervised Sale Process, Subject to Court and Regulatory Approvals –
Apr 15, 2024 07:00 am ET
Labcorp Announces First-of-Its-Kind Test for Early Indication of Neurodegenerative Diseases and Brain Injuries Using a Blood Draw
Innovative GFAP blood biomarker test expands Labcorp's portfolio of tests for diseases including Alzheimer's disease, multiple sclerosis, glioblastoma and brain injuries
Apr 11, 2024 06:59 am ET
Labcorp Declares Quarterly Dividend
BURLINGTON, N.C., April 11, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that its Board of Directors has declared a cash dividend of $0.72 per share of common stock. The dividend will be payable on June 12, 2024, to stockholders of record as of the close of business on May 28, 2024.
Apr 10, 2024 06:49 am ET
Labcorp Receives FDA Emergency Use Authorization for Mpox PCR Test Home Collection Kit
The first at-home mpox testing kit provides patients with convenience and privacy to test for mpox, supports physicians in detection and treatment
Apr 08, 2024 07:00 am ET
Apr 05, 2024 07:00 am ET
Labcorp Launches Labcorp® Plasma Detect™ Extending Leadership into Molecular Residual Disease (MRD) Clinical Research
Labcorp Plasma Detect is the first clinically validated, whole-genome sequencing MRD solution for early-stage colon cancer
Apr 02, 2024 07:00 am ET
Labcorp to Present Diverse Portfolio of Precision Oncology Research at the Annual Meeting of the American Association for Cancer Research
Researchers to present on topics ranging from molecular residual disease and immunotherapy to whole-genome sequencing
Apr 01, 2024 08:00 am ET
Xcell Biosciences Strengthens Cell and Gene Therapy Collaboration With Labcorp
Xcell Biosciences Inc. (Xcellbio), an instrumentation company focused on cell and gene therapy applications, today announced it has added new elements to its research collaboration agreement with Labcorp, a global leader of innovative and comprehensive laboratory services. Through the expanded collaboration, Labcorp will participate in the beta program for Xcellbio’s clinical manufacturing line of AVATAR™ instruments and has been given an observer seat on the company’s board of directors. In exchange, Labcorp has increased its strategic investment in Xcellbio. Financial details of the investme
Mar 29, 2024 09:00 am ET
The Prelude Network® Names Labcorp Its Preferred Genetic Carrier Screening Lab
Expanded partnership to help increase patient access to critical genetic screening services including genetic counseling and test result turnaround time 
Mar 28, 2024 08:00 am ET
Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics Business
Transaction to enhance Labcorp's laboratory services network and expand access to the company's high-quality clinical laboratory services
Mar 27, 2024 07:00 am ET
Labcorp to Announce First Quarter Financial Results on April 25, 2024
BURLINGTON, N.C., March 27, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the first quarter of 2024 before the market opens on Thursday, April 25, 2024. The company will host a conference call and webcast beginning at 9 a.m. ET that day to discuss the results. The earnings press release and accompanying financial information will be posted on the Labcorp Investor Relations website.
Feb 21, 2024 08:19 am ET
Diagnostics Industry Leader Gary Huff Appointed to Biomerica Strategic Advisory Board
Biomerica, Inc. (NASDAQ: BMRA), a global biomedical company leading the way in innovative gastroenterology solutions, proudly announces the appointment of Gary Huff to its Strategic Advisory Board (SAB). Mr. Huff, former CEO of Diagnostics at...
Feb 15, 2024 05:56 am ET
Feb 07, 2024 09:05 am ET
Labcorp Elevates Employee Health Benefits with WeightWatchers for Business Full-Spectrum Weight Health Platform
WeightWatchers (NASDAQ: WW), (“WeightWatchers,” “WW,” or the “Company”) today announced that Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, is deepening its existing partnership with WeightWatchers for...
Feb 01, 2024 06:00 am ET
Labcorp Named One of the World's Most Admired Companies™ by FORTUNE® Magazine
BURLINGTON, N.C., Feb. 1, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, has once again been named to FORTUNE® magazine's list of the World's Most Admired Companies™, a recognition of the most respected and reputable companies globally.
Jan 31, 2024 06:00 am ET
Labcorp Launches New Test for Risk Assessment and Prognosis of Severe Preeclampsia in Pregnant Women
B•R•A•H•M•S™ sFlt-1/PlGF KRYPTOR™ Test System is available through physicians and is the first FDA-cleared biomarker test to aid in the risk assessment of progression to preeclampsia with severe features, a leading cause of maternal and fetal mortality in the U.S.1
Jan 16, 2024 05:58 am ET
Labcorp to Announce Fourth Quarter and Full Year 2023 Financial Results on February 15, 2024
BURLINGTON, N.C., Jan. 16, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the fourth quarter and full year 2023 before the market opens on Thursday, February 15, 2024. The company will host a conference call and webcast beginning at 9 a.m. ET that day to discuss the results. The earnings press release and accompanying financial information will be posted on the Labcorp Investor Relations website.
Jan 12, 2024 05:57 am ET
Labcorp Declares Quarterly Dividend
BURLINGTON, N.C., Jan. 12, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a leading global life sciences company, announced today that its Board of Directors has declared a cash dividend of $0.72 per share of common stock. The dividend will be payable on March 13, 2024, to stockholders of record as of the close of business on February 27, 2024.
Jan 10, 2024 07:02 am ET
Labcorp and Hawthorne Effect Collaborate to Bring Clinical Trials Directly to Patients and Investigators in Local Communities
Collaboration Aims to Improve Patient Experience, Accessibility and Efficiency in Decentralized Clinical Trials
Jan 02, 2024 06:00 am ET
Labcorp to Speak at the 42nd Annual J.P. Morgan Healthcare Conference
BURLINGTON, N.C., Jan. 2, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that members of the executive management team will participate in a fireside chat at the 42nd Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 9 at 4:30 p.m. (PT).
Nov 20, 2023 06:00 am ET
Labcorp and Legacy Health Finalize Comprehensive Laboratory Relationship
Agreement Expands Access to Labcorp's Diagnostics Capabilities and Services
Nov 16, 2023 06:00 am ET
Tigerlily Foundation and Labcorp Launch I AM INCLUDED Framework to Increase Clinical Trial Diversity, Accelerate Delivery of Innovative Cancer Treatments
BURLINGTON, N.C. and WASHINGTON, Nov. 16, 2023 /PRNewswire/ -- Today, the Tigerlily Foundation  (Tigerlily), a leading breast cancer patient advocacy organization, and Labcorp, a global leader of innovative and comprehensive laboratory services, announced the launch of I AM INCLUDED, a co-developed, modernized, multi-stakeholder framework for sharing best practices of U.S. diverse clinical trial site leaders for inclusive cancer clinical trials. 
Nov 08, 2023 06:00 am ET
Ovia Health Unveils New Fertility and Family Building Benefit
Expanded offering adds inclusive end-to end support for pre-conception, adoption and surrogacy while removing barriers to equitable care access
Oct 26, 2023 06:58 am ET
Labcorp Announces 2023 Third Quarter Results
Company Updates Full-Year Guidance
Oct 12, 2023 06:56 am ET
Labcorp Declares Quarterly Dividend
BURLINGTON, N.C., Oct. 12, 2023 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that its Board of Directors has declared a cash dividend of $0.72 per share of common stock. The dividend will be payable on December 12, 2023, to stockholders of record as of the close of business on November 8, 2023.
Oct 11, 2023 08:30 am ET
Labcorp Launches New Test to Accelerate Path to Diagnosis of Alzheimer's Disease
Test is available through physicians for use with patients being evaluated for possible Alzheimer's disease or other causes of cognitive impairment
Oct 04, 2023 04:25 pm ET
LABCORP AND BAYSTATE HEALTH ANNOUNCE STRATEGIC RELATIONSHIP FOR DIAGNOSTIC LABORATORY SERVICES
Labcorp to acquire Baystate Health's outreach laboratory business and select operating assets
Sep 29, 2023 06:57 am ET
Labcorp to Announce Third Quarter Financial Results on October 26, 2023
BURLINGTON, N.C., Sept. 29, 2023 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the third quarter of 2023 before the market opens on Thursday, October 26, 2023. The company will host a conference call and webcast beginning at 9 a.m. ET that day to discuss the results. The earnings press release and accompanying financial information will be posted on the Labcorp Investor Relations website.
Sep 27, 2023 11:15 am ET
Graves Gilbert, Circuit Clinical, and Labcorp Join Forces to Bring Clinical Trials to Patients across South Central Kentucky
BUFFALO, N.Y., Sept. 27, 2023 /PRNewswire/ -- Graves Gilbert, a multispecialty clinic comprised of more than 200 providers representing over 30 medical specialties in Bowling Green, Kentucky, and surrounding counties, is proud to announce a collaboration with Circuit Clinical, an integrated research organization, to bring clinical trials to patients in South Central Kentucky. The partnership supports broader efforts to bring clinical research to community settings, advance medical treatments, and improve equitable healthcare for diverse and medically underserved rural communities.
Sep 14, 2023 06:56 am ET
Labcorp to Present Strategy, Business and Financial Outlook at Investor Day
BURLINGTON, N.C., Sept. 14, 2023 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, is hosting an Investor Day beginning at 1:00 p.m. ET today in New York City, expected to conclude by approximately 4:00 p.m. ET. The event will highlight the company's go-forward strategy from Labcorp Chairman & CEO Adam Schechter, followed by business overviews and a longer-term financial outlook by members of the leadership team.
Aug 08, 2023 04:05 pm ET
Singular Genomics Appoints Genomics Veteran Marcia Eisenberg, Ph.D., to Board of Directors
Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced the appointment of Marcia Eisenberg, Ph.D., to the...
Jul 31, 2023 06:57 am ET
Labcorp to Host Investor Day on September 14, 2023
BURLINGTON, N.C., July 31, 2023 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services,  today announced it will host an Investor Day on Thursday, September 14, 2023, in New York City, beginning at 1:00 p.m. ET and is expected to conclude by approximately 4:00 p.m. ET.
Jul 27, 2023 06:57 am ET
Labcorp Announces 2023 Second Quarter Results
Company Provides Full-Year Guidance
Jul 24, 2023 04:27 pm ET
Enzo Biochem Completes Sale of Clinical Laboratory to Labcorp
Enzo Biochem, Inc. (NYSE:ENZ) today announced that it has closed a transaction to sell certain assets of Enzo’s Clinical laboratory division (Enzo Clinical Labs) to Laboratory Corporation of America Holdings (Labcorp) (NYSE:LH) pursuant to an Asset...
Jul 24, 2023 07:22 am ET
Labcorp OnDemand Offers Menopause Test to Consumers
Labcorp's Menopause Test and Menopause Support Program provide women with insights to guide their healthcare decisions
Jul 13, 2023 08:00 am ET
Labcorp Finalizes Strategic Relationship with Jefferson Health
BURLINGTON, N.C., July 13, 2023 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader in innovative and comprehensive laboratory services, today announced the completion of the previously announced transaction that establishes a strategic relationship with Jefferson Health (Jefferson), the largest health system serving the greater Philadelphia and Southern New Jersey region.
Jul 13, 2023 06:58 am ET
Labcorp Declares Quarterly Dividend
BURLINGTON, N.C., July 13, 2023 /PRNewswire/ -- Labcorp (NYSE: LH), a leading global life sciences company, announced today that its Board of Directors has declared a cash dividend of $0.72 per share of common stock. The dividend will be payable on September 8, 2023, to stockholders of record as of the close of business on August 8, 2023.
Jul 11, 2023 07:00 am ET
LABCORP AND LEGACY HEALTH AGREE TO COMPREHENSIVE LABORATORY RELATIONSHIP
Agreement Will Expand Access to Labcorp's Diagnostics Capabilities and Improve Services
Jul 03, 2023 07:05 am ET
Fortrea Launches as Leading, Global Contract Research Organization Positioned to Bring Life-Changing Therapies to Patients Faster
Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced that it has successfully completed its previously announced spin-off from Labcorp (NYSE: LH). On June 30 at 11:59 p.m., Fortrea became an...
Jul 03, 2023 06:57 am ET
Labcorp Completes Spin-off of Fortrea
BURLINGTON, N.C., July 3, 2023 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced that it has completed the spin-off of Fortrea, the newly formed independent Contract Research Organization providing Phase I-IV clinical trial management, patient access and technology solutions to pharmaceutical and biotechnology organizations around the world. Fortrea will begin trading on the NASDAQ Stock Market under the symbol "FTRE" effective at the market opening today.
Jun 29, 2023 07:02 am ET
Labcorp to Announce Second Quarter Financial Results on July 27, 2023
BURLINGTON, N.C., June 29, 2023 /PRNewswire/ -- Labcorp (NYSE: LH), a leading global life sciences company, will release its financial results for the second quarter of 2023 before the market opens on Thursday, July 27, 2023. The company will host a conference call and webcast beginning at 9 a.m. ET that day to discuss the results. The earnings press release and accompanying financial information will be posted on the Labcorp Investor Relations website.
Jun 28, 2023 06:08 pm ET
Fortrea Holdings and PHINIA Set to Join S&P SmallCap 600
NEW YORK, June 28, 2023 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P SmallCap 600 effective prior to the opening of trading on Thursday, July 6:
Jun 12, 2023 06:30 pm ET
LABCORP ANNOUNCES PRICING OF FORTREA $570 MILLION NOTES OFFERING IN CONNECTION WITH ANTICIPATED FORTREA SPINOFF
BURLINGTON, N.C., June 12, 2023 /PRNewswire/ -- Labcorp (NYSE: LH), a leading global life sciences company, today announced that Fortrea Holdings Inc., a wholly owned subsidiary of Labcorp ("Fortrea"), has priced an offering of $570 million of senior secured notes due 2030 (the "Notes"), in connection with the previously announced spinoff of Fortrea into a separate publicly traded company (the "Spinoff").
Jun 12, 2023 05:28 pm ET
LABCORP ANNOUNCES ADDITIONAL INFORMATION IN CONNECTION WITH ITS SPIN-OFF OF FORTREA
BURLINGTON, N.C., June 12, 2023 /PRNewswire/ -- Labcorp (NYSE: LH), a leading global life sciences company, previously announced the following record and distribution dates for its spin-off of Fortrea Holdings Inc., a wholly owned subsidiary of Labcorp ("Fortrea"):
Jun 09, 2023 04:43 pm ET
Labcorp Announces Information in Connection with its Spin-off of Fortrea
BURLINGTON, N.C., June 9, 2023 /PRNewswire/ -- Labcorp (NYSE: LH), a leading global life sciences company, today announced the following record and distribution dates for the spin-off of Fortrea Holdings Inc., a wholly owned subsidiary of Labcorp ("Fortrea"):
Jun 08, 2023 09:08 am ET
Labcorp Announces Launch of Fortrea's Notes Offering in Connection with Anticipated Spinoff
BURLINGTON, N.C., June 8, 2023 /PRNewswire/ -- Labcorp (NYSE: LH), a leading global life sciences company, today announced that Fortrea Holdings Inc., a wholly owned subsidiary of Labcorp ("Fortrea"), has launched an offering of senior secured notes due 2030 (the "Notes"), subject to market conditions and other customary factors, in connection with the previously announced spinoff of Fortrea into a separate publicly traded company (the "Spinoff").
Jun 07, 2023 07:00 am ET
Labcorp Appoints Dr. Paul Rothman to Board of Directors
Health system executive brings three decades of medical enterprise experience to Labcorp
Jun 05, 2023 06:57 am ET
Labcorp's Planned Spin-off, Fortrea, to Host 2023 Investor Day
BURLINGTON, N.C., June 5, 2023 /PRNewswire/ -- Labcorp (NYSE: LH), a leading global life sciences company, today announced Fortrea, the new company to be formed by the planned spin-off of Labcorp's Clinical Development and Commercialization Services business, will host its inaugural Investor Day on Tuesday, June 6, 2023, in New York City at 9 a.m. ET.
May 31, 2023 04:35 pm ET
Labcorp Plasma Focus™ Liquid Biopsy Test Now Available
Liquid biopsy test for cancer patients enables oncologists to identify targeted therapies and improve care
May 16, 2023 07:00 am ET
Labcorp and Providence Expand Strategic Laboratory Relationship
Patients and Providers in Oregon Region Will Gain Broader Access to Labcorp's Diagnostic Testing and Laboratory Services
May 04, 2023 06:56 am ET
LABCORP TO WEBCAST ITS ANNUAL MEETING OF SHAREHOLDERS
BURLINGTON, N.C., May 4, 2023 /PRNewswire/ -- Labcorp (NYSE: LH), a leading global life sciences company, today announced that its Annual Meeting of Shareholders will be webcast live on May 11 at 9:00 a.m. ET and can be viewed online on the Labcorp Investor Relations website. An archived replay of the webcast will be available for one year. 
May 03, 2023 06:59 am ET
LABCORP AND JEFFERSON HEALTH ANNOUNCE STRATEGIC LABORATORY RELATIONSHIP
Physicians and Patients Will Gain Access to Enhanced Laboratory Services and Advanced Diagnostic Testing
May 02, 2023 08:30 pm ET
SHAREHOLDER ALERT: Weiss Law Investigates Enzo Biochem, Inc.
NEW YORK, May 2, 2023 /PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Enzo Biochem, Inc. ("Enzo Biochem" or the "Company") (NYSE: ENZ) in connection with its acquisition by Laboratory Corporation of America Holdings (NYSE: LH) ("Labcorp").  The transaction value is approximately $146 million.
Apr 25, 2023 06:52 am ET
Labcorp Announces 2023 First Quarter Results
Company Updates Full-Year Guidance
Apr 06, 2023 06:51 am ET
LABCORP DECLARES QUARTERLY DIVIDEND
BURLINGTON, N.C., April 6, 2023 /PRNewswire/ -- Labcorp (NYSE: LH), a leading global life sciences company, announced today that its Board of Directors has declared a cash dividend of $0.72 per share of common stock. The dividend will be payable on June 8, 2023, to stockholders of record as of the close of business on May 18, 2023.
Apr 03, 2023 08:00 am ET
LABCORP EXPANDS ACCESS TO COLORECTAL CANCER SCREENING THROUGH PARTNERSHIP WITH THE CONFERENCE OF NATIONAL BLACK CHURCHES
Partnership will distribute screening kits to communities at higher risk of colon cancer
Mar 31, 2023 06:59 am ET
LABCORP TO ANNOUNCE FIRST QUARTER FINANCIAL RESULTS ON APRIL 25, 2023
BURLINGTON, N.C., March 31, 2023 /PRNewswire/ -- Labcorp (NYSE: LH), a leading global life sciences company, will release its financial results for the first quarter of 2023 before the market opens on Tuesday, April 25, 2023. The company will host a conference call and webcast beginning at 9 a.m. ET that day to discuss the results. The earnings press release and accompanying financial information will be posted on the Labcorp Investor Relations website.
Feb 22, 2023 09:00 am ET
Ovia HealthTM Expands Digital Platform Capabilities to Include Menopause Tracking
Ovia Health, a trusted digital health platform for women and families, today announced the expansion of its Ovia® app, which will now allow women to track menopause symptoms and access valuable resources and support to address the transition to menopause/perimenopause. The technology is available through Ovia’s consumer application and enterprise offer
Feb 16, 2023 07:00 am ET
Labcorp Announces 2022 Fourth Quarter and Full-Year Results
Labcorp (NYSE: LH), a leading global life sciences company, today announced results for the fourth quarter and year ended Dec. 31, 2022, full-year 2023 guidance.
Feb 09, 2023 07:00 am ET
Labcorp Unveils New Name for Future Independent Clinical Development Business - Fortrea
Labcorp (NYSE: LH), a leading global life sciences company, today announced that the new company to be formed by the planned spin-off of its Clinical Development business will be known as Fortrea. Upon completion of the spin-off from Labcorp, Fortrea will operate as an independent, publicly traded global CRO that offers comprehensive drug and medical device de
Jan 18, 2023 04:28 pm ET
Labcorp to Announce Fourth Quarter and Full Year 2022 Financial Results on February 16, 2023
Labcorp (NYSE: LH), a leading global life sciences company, will release its financial results for the fourth quarter and full year 2022 before the market opens on Thursday, Feb. 16, 2023. The company will host a conference call and webcast beginning at 9 a.m. ET that day to discuss the results. The earnings press release and accompanying financial informatio
Jan 12, 2023 04:22 pm ET
Labcorp Declares Quarterly Dividend
Labcorp (NYSE: LH), a leading global life sciences company, announced today that its Board of Directors has declared a cash dividend of $0.72 per share of common stock. The dividend will be payable on March 13, 2023, to stockholders of record as of the close of business on Feb. 23, 2023.
Jan 05, 2023 07:00 am ET
Thomas Pike to Join Labcorp as President and Chief Executive Officer of Its Drug Development Clinical Development Business Unit
“Tom’s global leadership experience and proven record in the contract research organization (CRO), healthcare and services industries make him the ideal person to lead the Clinical Development business in its next chapter,” said Adam Schechter, chairman and CEO of Labcorp. “Tom has the strategic vision and deep operational experience to expand the new company’s market position, accelerate growth and deliver value for customers and stakeholders. I am confident in his ability to build on the Clinical Development business and position it for continued success.”
Jan 03, 2023 04:29 pm ET
Labcorp to Speak at the 41st Annual J.P. Morgan Healthcare Conference
Labcorp (NYSE: LH), a leading global life sciences company, today announced that members of the executive management team will participate in a fireside chat at the 41st Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 10 at 4:30 p.m. (PT).
Dec 08, 2022 04:30 pm ET
Labcorp Opens New Los Angeles Based Laboratory
Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has begun operations at a new, larger anatomic pathology and histology (APH) laboratory in Los Angeles, expanding the company’s global central laboratory capabilities.
Nov 14, 2022 08:23 am ET
Oracle Cerner Technology to Manage Hospital Labs in 10 States
Cerner's lab information systems selected to help Labcorp streamline operations and enhance patient experiences for a leading health system 
Oct 31, 2022 04:26 pm ET
Labcorp to Speak at the Credit Suisse 31st Annual Healthcare Conference
Labcorp (NYSE: LH), a leading global life sciences company, today announced that members of the executive management team will participate in a fireside chat at the Credit Suisse 31st Annual Healthcare Conference on Tuesday, Nov. 8, at 1:25 p.m. PT.
Oct 27, 2022 07:00 am ET
Labcorp Announces 2022 Third Quarter Results
Labcorp (NYSE: LH), a leading global life sciences company, today announced results for the third quarter ended Sept. 30, 2022, and updated full-year guidance.
Oct 13, 2022 04:30 pm ET
Labcorp Appoints Google Cloud Executive Kirsten Kliphouse to Its Board of Directors
Labcorp (NYSE: LH), a leading global life sciences company, today announced that Kirsten Kliphouse, president of Americas, Google Cloud, has joined its Board of Directors as an independent member.
Oct 12, 2022 04:45 pm ET
Labcorp Declares Quarterly Dividend
Labcorp (NYSE: LH), a leading global life sciences company, announced today that its Board of Directors has declared a cash dividend of $0.72 per share of common stock. The dividend will be payable on Dec. 9, 2022, to stockholders of record as of the close of business on Nov. 17, 2022.
Oct 03, 2022 07:08 am ET
Labcorp Establishes Comprehensive Laboratory Relationship With Ascension
Labcorp (NYSE: LH), a leading global life sciences company, today announced the completion of transactions that establish a long-term laboratory relationship with Ascension, one of the leading non-profit and Catholic health systems in the United States.
Sep 27, 2022 07:00 am ET
Labcorp to Announce Third Quarter Financial Results on October 27, 2022
Labcorp (NYSE: LH), a leading global life sciences company, will release its financial results for the third quarter of 2022 before the market opens on Thursday, Oct. 27, 2022. The company will host a conference call and webcast beginning at 9 a.m. ET that day to discuss the results. The earnings press release and accompanying financial information will be po
Sep 06, 2022 06:59 am ET
Labcorp to Speak at the Baird 2022 Global Healthcare Conference
Labcorp (NYSE: LH), a leading global life sciences company, today announced that members of the executive management team will participate in a fireside chat at the Baird 2022 Global Healthcare Conference on Tuesday, Sept. 13, at 9:05 a.m. ET.
Aug 23, 2022 04:30 pm ET
Labcorp Acquires Clinical Outreach Laboratory Services From RWJBarnabas Health
Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has closed its acquisition of RWJBarnabas Health’s outreach laboratory business and select related assets. RWJBarnabas Health is New Jersey’s largest academic health system.
Aug 09, 2022 06:50 am ET
BD, Labcorp Collaborate to Develop Flow Cytometry-Based Companion Diagnostics for Matching Patients with Treatments
Companies combine key capabilities to advance flow cytometry as an essential companion diagnostic modality for cancer and other diseases
Jul 28, 2022 07:00 am ET
Labcorp Announces 2022 Second Quarter Results
Labcorp (NYSE: LH), a leading global life sciences company, today announced results for the second quarter ended June 30, 2022, and updated full-year guidance.
Jul 28, 2022 06:59 am ET
Labcorp to Spin Off Clinical Development Business
Labcorp (NYSE: LH) (the “Company”), a leading global life sciences company, today announced that its Board of Directors has authorized the Company to pursue a spin-off of the Company’s wholly owned Clinical Development business to Labcorp shareholders through a tax-free transaction. The planned spin-off will result in two independent, publicly traded companie
Jul 22, 2022 09:51 am ET
Labcorp Earns Top Score on 2022 Disability Equality Index
Labcorp (NYSE: LH), a leading global life sciences company, today announced that it scored 100, the highest score possible, on the 2022
Jul 19, 2022 04:25 pm ET
New Labcorp Test Report Helps Identify Insect Stings and Improve Therapy Decisions to Combat Allergic Reactions
Nearly 10 million people in the United States have a history of systemic or anaphylactic reaction to insect stings, with the risk of a severe and potentially life-threatening allergic reaction. To help facilitate more effective venom therapy, Labcorp (NYSE: LH), a leading global life sciences company, has launched its unique Labcorp Clinical Decision Support (CDS
Jul 18, 2022 04:30 pm ET
Labcorp Expands Automated Clinical Trial Kit Production Line at European Operations Center
Labcorp® (NYSE: LH), a leading global life sciences company, today announced an expansion of its automated clinical trial kit production line in Mechelen, Belgium. Once completed, expansion will allow for clinical trial test kits to be fulfilled in Mechelen for more than 70 countries throughout Europe, the Middle East and Africa (EMEA). This is up from 27 countri
Jul 14, 2022 05:43 pm ET
Labcorp to Announce Second Quarter Financial Results on July 28, 2022
Labcorp (NYSE: LH), a leading global life sciences company, will release its financial results for the second quarter of 2022 before the market opens on Thursday, July 28, 2022. The company will host a conference call and webcast beginning at 9 a.m. EDT that day to discuss the results. The earnings press release and accompanying financial information will be
Jul 14, 2022 04:30 pm ET
Labcorp Declares Quarterly Dividend
Labcorp (NYSE: LH) (the Company), a leading global life sciences company, announced today that its Board of Directors (the Board) has declared a cash dividend of $0.72 per share of common stock. The dividend will be payable on September 9, 2022, to stockholders of record as of the close of business on August 18, 2022.
Jul 13, 2022 07:00 am ET
Labcorp Launches New Test to Identify and Confirm Neurodegenerative Disease
Labcorp (NYSE: LH), a leading global life sciences company, today announced the launch of the first widely accessible test that provides direct evidence of neurodegeneration and neuronal injury. The new Neurofilament Light Chain (NfL) blood test will allow doctors to identify and verify signs of neurodegenerative disease, enabling physicians to provide a more eff
Jul 11, 2022 04:30 pm ET
Labcorp Forms Strategic Partnership With MD Anderson Cancer Center Foundation Spain to Increase Access to Early Phase Oncology Clinical Trials
Labcorp (NYSE: LH), a leading global life sciences company, today announced it has formed a strategic partnership with MD Anderson Cancer Center Foundation Spain, a non-profit organization whose objectives are to beat cancer and to increase accessibility of early phase oncology clinical trials. Through this collaboration, oncology clinical trials managed by Labco
Jul 06, 2022 07:00 am ET
Labcorp First National Laboratory to Offer Monkeypox Test
Labcorp (NYSE: LH), a leading global life sciences company, today announced it will begin testing for monkeypox using the U.S. Centers for Disease Control and Prevention’s (CDC) orthopoxvirus test, which detects all non-smallpox related orthopoxviruses, including monkeypox. This effort is part of the Administration’s commitment to quickly increase monkeypox testi
Jun 28, 2022 04:15 pm ET
Labcorp Plans Laboratory Expansion in Japan Through BML Collaboration
Labcorp (NYSE: LH), a leading global life sciences company, today announced that it is enhancing its central laboratory presence and drug development capabilities in Japan through an expansion of CB Trial Laboratory, the central laboratory co-managed by Labcorp Drug Development and BML, a leading Japanese provider of clinical laboratory testing services.
Jun 24, 2022 06:53 am ET
 Tigerlily Foundation and Labcorp Collaborate to Increase Clinical Trial Diversity for Women of Color
Labcorp, a leading global life sciences company, and Tigerlily Foundation (Tigerlily), a leading breast cancer patient advocacy organization, today announced a new collaboration to increase clinical trial diversity for women of color and co-create health equity solutions. Labcorp has signed Tigerlily’s #InclusionPledge for Black Women, joining other healthcare an
Jun 21, 2022 07:09 am ET
Labcorp Enhances Clinical Trial and Drug Development Capabilities Through Real World Data Collaboration With HealthVerity
Labcorp® (NYSE: LH), a leading global life sciences company, today announced a new collaboration with HealthVerity, Inc.
Jun 02, 2022 05:19 pm ET
Labcorp Expands Access to Comprehensive Genomic Testing Through New Lung Cancer Program
Labcorp (NYSE: LH), a leading global life sciences company, understands the important and growing role of precision medicine and is working to ensure more people have access to targeted and personalized treatments. As part of this effort, the company is announcing a new sponsored testing program aimed at helping advanced non-small cell lung (NSCLC) cancer pat
May 18, 2022 04:30 pm ET
Labcorp Launches New Test for People With Skin Cancer
Finding treatment options for skin cancer may become easier with the launch of a new test by Labcorp (NYSE: LH), a leading global life sciences company. The new test measures Lymphocyte-activation gene 3 (LAG-3) expression levels by immunohistochemistry (IHC) in tumor tissue. LAG-3 is an immune-oncology target with demonstrable clinical benefit in patients wi
May 18, 2022 06:39 am ET
Labcorp Receives Emergency Use Authorization for First Non-Prescription At-Home Collection Kit for Combined COVID-19, Flu and RSV Detection
Labcorp (NYSE: LH), a leading global life sciences company, today announced the receipt of Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for a combined at-home collection kit available that simultaneously detects COVID-19, influenza A/B and respiratory syncytial virus (RSV), a common but contagious respiratory virus often s
May 17, 2022 12:01 pm ET
Labcorp to Speak at the UBS 2022 Global Healthcare Conference
Labcorp (NYSE: LH), a leading global life sciences company, today announced that members of the executive management team will participate in a fireside chat at the UBS 2022 Global Healthcare Conference on Tuesday, May 24 at 2:45 p.m. ET.
May 16, 2022 04:30 pm ET
Labcorp Launches First-of-its-kind At-home Collection Device for Diabetes Risk Testing
There is a new and convenient way for millions of individuals to assess whether they are at risk for developing diabetes. Labcorp (NYSE: LH), a leading global life sciences company, is making screening for diabetes easier with the launch of an at-home collection kit through
May 09, 2022 06:39 am ET
Labcorp Acquires Diagnostic Clinical Laboratory Services From AtlantiCare
Labcorp (NYSE: LH), a leading global life sciences company, and AtlantiCare, the largest health care organization in southern New Jersey, today announced that they have closed a transaction to expand their long-term strategic relationship. Labcorp will acquire select assets from AtlantiCare’s clinical outreach business, which serves the AtlantiCare Physician Group and Affiliated Physicians and their patients across southern New Jersey. The transaction is the latest in a series of new and expanded collaborations between Labcorp and health systems across the country, demonstrating the value that
May 04, 2022 01:30 pm ET
Labcorp to Webcast Its Annual Meeting of Shareholders
Labcorp (NYSE: LH), a leading global life sciences company, today announced that its Annual Meeting of Shareholders will be webcast live beginning May 11, at 9:00 a.m. ET via the Labcorp Investor Relations website. An archived replay of the webcast will be available for one year.
Apr 28, 2022 06:53 am ET
Labcorp Announces 2022 First Quarter Results
Labcorp (NYSE: LH), a leading global life sciences company, today announced results for the first quarter ended March 31, 2022, and updated full-year guidance.
Apr 22, 2022 10:51 am ET
Labcorp Launches Convenient Home Diagnostic Test Collection Service in Collaboration With Getlabs
Labcorp (NYSE: LH), a leading global life sciences company, today announced the launch of
Apr 19, 2022 04:30 pm ET
Labcorp Enhances Cell and Gene Therapy Development Support Through Collaboration With Xcell Biosciences
Labcorp (NYSE: LH), a leading global life sciences company, is collaborating with Xcell Biosciences, Inc. (Xcellbio), a leading developer of cell and gene therapy technologies, to advance critical work that helps clients effectively bring innovative cell and gene therapies to market.
Apr 07, 2022 06:57 am ET
Labcorp Initiates Quarterly Dividend
Labcorp (NYSE: LH), a leading global life sciences company, announced today that its Board of Directors (the Board) has declared a cash dividend of $0.72 per share of common stock. The dividend will be payable on June 9, 2022, to stockholders of record as of the close of business on May 19, 2022.
Mar 28, 2022 04:18 pm ET
Labcorp to Announce First Quarter Financial Results on April 28, 2022
Labcorp (NYSE: LH), a leading global life sciences company, will release its financial results for the first quarter of 2022 before the market opens on Thursday, April 28, 2022. The company will host a conference call and webcast beginning at 9 a.m. EDT that day to discuss the results. The earnings press release and accompanying financial information will be posted on the
Mar 17, 2022 07:30 am ET
New Labcorp Offering Makes Detecting, Measuring Unintentional Gluten Consumption Simple and Effective
As awareness of celiac disease and non-celiac gluten sensitivity (NCGS) increases in the United States and around the globe, more people are adhering to strict diets to avoid gluten exposure and the negative effects it can have on their health.
Mar 09, 2022 08:11 am ET
Labcorp Enters Into Strategic Relationship With Prisma Health
Labcorp (NYSE: LH), a leading global life sciences company, is entering into a strategic laboratory relationship with Prisma Health, a nonprofit and the largest health system in South Carolina.
Feb 21, 2022 06:55 am ET
Labcorp Completes Acquisition of Personal Genome Diagnostics
Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has closed its acquisition of Personal Genome Diagnostics Inc. (
Feb 11, 2022 09:00 pm ET
Bragar Eagel & Squire, P.C. Is Investigating Everbridge, Aligos, Labcorp., and SunPower and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Everbridge, Inc. (NASDAQ: EVBG), Aligos Therapeutics, Inc. (NASDAQ: ALGS), Laboratory Corporation of America Holdings (NYSE:...
Feb 10, 2022 07:08 am ET
Labcorp Announces 2021 Fourth Quarter and Full-Year Results
Labcorp (NYSE: LH), a leading global life sciences company, today announced results for the fourth quarter and year ended Dec. 31, 2021, full-year 2022 guidance and longer-term outlook.
Feb 09, 2022 04:55 pm ET
Labcorp Enters Comprehensive, Long-Term Laboratory Relationship With Ascension
Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has entered into agreements to create a comprehensive strategic relationship with Ascension, one of the nation’s leading Catholic and non-profit health systems. Through the expansive strategic collaboration, Labcorp will manage Ascension’s hospital-based laboratories in 10 sta
Feb 07, 2022 07:30 am ET
Labcorp Opens New Laboratory in South Bend, Expanding Services and Access in the Midwest
Labcorp (NYSE: LH), a leading global life sciences company, today announced the opening of a new diagnostics laboratory in South Bend, Indiana, allowing the company to enhance service levels and offerings to patients and physicians in South Bend and throughout the region.
Feb 06, 2022 09:00 pm ET
Bragar Eagel & Squire, P.C. Is Investigating Laboratory Corp., Hollysys Automation, and Cronos Group and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Laboratory Corporation of America Holdings (NYSE: LH), Hollysys Automation Technologies Ltd. (NASDAQ: HOLI), and Cronos...
Feb 04, 2022 07:13 am ET
Labcorp Launches Labcorp OnDemand Digital Health Platform
Labcorp (NYSE: LH), a leading global life sciences company, today announced the launch of Labcorp OnDemand, an easy experience where individuals can purchase Labcorp OnDemand tests online, collect samples in the convenience of their home, or schedule test appointments at one of Labcorp’s 2,000 patient service centers (PSCs), including Labcorp at Walgreens loc
Feb 03, 2022 08:31 am ET
Investigation Alert: Kessler Topaz Meltzer & Check, LLP is Investigating Securities Fraud Claims on Behalf of Laboratory Corporation of America Holdings (NYSE: LH) Investors
The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of Laboratory Corporation of America Holdings (NYSE: LH) (“Labcorp”). Labcorp...
Feb 02, 2022 04:30 pm ET
Labcorp Named to Fortune® Magazine’s 2022 ‘World’s Most Admired Companies’ List for the Fourth Time
Labcorp (NYSE: LH), a leading global life sciences company, has been named to FORTUNE® magazine's 2022 list of the World’s Most Admired Companies, marking its fourth appearance on the list. The annual survey, conducted by FORTUNE and Korn Ferry, a global organizational consulting firm, asks top executives, directors and financial analysts to identify the companies with the strongest reputations across various industries.
Jan 31, 2022 09:00 pm ET
Bragar Eagel & Squire, P.C. Is Investigating Everbridge, Hollysys, Aligos, and Labcorp. and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Everbridge, Inc. (NASDAQ: EVBG), Hollysys Automation Technologies Ltd. (NASDAQ: HOLI), Aligos Therapeutics, Inc. (NASDAQ:...
Jan 27, 2022 04:15 pm ET
Labcorp Earns 100% on Human Rights Campaign Foundation’s Annual Scorecard on LGBTQ+ Workplace Equality
Labcorp (NYSE: LH), a leading global life sciences company, today announced that it received a perfect score of 100% on the Human Rights Campaign Foundation’s 2022 Corporate Equality Index (CEI), the nation’s foremost benchmarking survey and report measuring corporate policies and practices related to LGBTQ+ workplace equality.
Jan 27, 2022 02:53 pm ET
Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Laboratory Corporation of America Holdings (LH) Investigation
Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Laboratory Corporation of America Holdings (“Labcorp” or “the Company”) (NYSE: LH). Investors who purchased Labcorp securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site:
Jan 27, 2022 11:41 am ET
INVESTIGATION REMINDER: The Schall Law Firm Encourages Investors in Laboratory Corporation of America Holdings with Losses of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Laboratory Corporation of America Holdings (“Labcorp” or “the Company”) (NYSE:
Jan 26, 2022 09:00 pm ET
Bragar Eagel & Squire, P.C. Is Investigating Aligos, SunPower, and Labcorp and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Aligos Therapeutics, Inc. (NASDAQ: ALGS), SunPower Corporation (NASDAQ: SPWR), and Laboratory Corporation of America...
Jan 26, 2022 06:42 pm ET
INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Laboratory Corporation of America Holdings with Losses of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Laboratory Corporation of America Holdings (“Labcorp” or “the Company”) (NYSE:
Jan 26, 2022 09:00 am ET
Labcorp to Offer Risk-Scoring Test for People With Advanced Liver Fibrosis Due to NASH
For the millions of people in the United States living with an advanced form of chronic liver disease, simply understanding the potential for future complications could help stave off severe damage and even a transplant. Labcorp (NYSE: LH), a leading global life sciences company, is making this possible by offering the Enhanced Liver Fibrosis (ELF™) test. Developed by Siemens Healthineers, the physician-ordered blood test helps assess the risk of disease progression in individuals—opening the door for improved outcomes. The test has been granted De Novo marketing authorization by the U.S. Food
Jan 16, 2022 09:00 pm ET
Bragar Eagel & Squire, P.C. Is Investigating LifeStance Health, CareDx, Seer, and Laboratory Corp. and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against LifeStance Health Group, Inc. (NASDAQ: LFST), CareDx, Inc. (NASDAQ: CDNA), Seer, Inc. (NASDAQ: SEER), and Laboratory...
Jan 12, 2022 09:00 am ET
GenomOncology Pathology Workbench to Support OmniSeq INSIGHT℠, a Genomic and Immune Profiling Test That Identifies Potential Treatment and Clinical Trial Options for Solid Tumors
CLEVELAND, Jan. 12, 2022 /PRNewswire/ -- GenomOncology announced today that GenomOncology (GO) Pathology Workbench has been selected by Labcorp's OmniSeq to support the analysis and reporting of OmniSeq INSIGHT℠, a comprehensive genomic and immune profiling test for solid tumors.
Jan 11, 2022 09:00 pm ET
Bragar Eagel & Squire, P.C. Is Investigating Laboratory Corp., Hollysys Automation, and Cronos Group and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Laboratory Corporation of America Holdings (NYSE: LH), Hollysys Automation Technologies Ltd. (NASDAQ: HOLI), and Cronos...
Jan 10, 2022 09:00 pm ET
LABORATORY CORPORATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Laboratory Corporation of America Holdings on Behalf of Laboratory Corporation Stockholders and Encourages Investors to Conta
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Laboratory Corporation of America Holdings (“Labcorp” or the “Company”) (NYSE: LH) on behalf of Labcorp stockholders. Our investigation concerns whether Labcorp has violated the federal securities laws and/or engaged in other unlawful business practices.
Jan 10, 2022 04:32 pm ET
Labcorp to Announce Fourth Quarter and Full Year 2021 Financial Results on February 10, 2022
Labcorp (NYSE: LH), a leading global life sciences company, will release its financial results for the fourth quarter and full year 2021 before the market opens on Thursday, February 10, 2022. The company will host a conference call and webcast beginning at 9 a.m. ET that day to discuss the results. The earnings release and accompanying financial information will be posted on the
Jan 10, 2022 12:30 am ET
SHAREHOLDER ALERT: Robbins LLP Investigates Laboratory Corporation of America Holdings (LH) on Behalf of Shareholders
Shareholder rights law firm Robbins LLP is investigating Laboratory Corporation of America Holdings (NASDAQ: LH) to determine whether certain Labcorp officers and directors violated securities laws and breached fiduciary duties to shareholders. Labcorp is a clinical laboratory organization.
Jan 06, 2022 03:02 pm ET
INVESTOR ALERT: Kirby McInerney LLP Announces an Investigation of Shareholder Claims on Behalf of Laboratory Corporation of America Holdings (LH) Investors
The law firm of Kirby McInerney LLP is investigating potential claims against Laboratory Corporation of America Holdings (“Labcorp” or the “Company”) (NYSE: LH). The investigation concerns whether Labcorp has violated the federal securities laws...
Jan 06, 2022 03:00 pm ET
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Laboratory Corporation of America Holdings (LH) on Behalf of Investors
Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Laboratory Corporation of America Holdings (“Labcorp” or the “Company”) (NYSE:
Jan 06, 2022 01:15 pm ET
The Law Offices of Frank R. Cruz Announces Investigation of Laboratory Corporation of America Holdings (LH) on Behalf of Investors
The Law Offices of Frank R. Cruz announces an investigation of Laboratory Corporation of America Holdings (“Labcorp” or the “Company”) (NYSE:
Jan 06, 2022 12:03 pm ET
Investigation Alert: Kessler Topaz Meltzer & Check, LLP is Investigating Securities Fraud Claims on Behalf of Laboratory Corporation of America Holdings (NYSE: LH) Investors
The law firm of Kessler Topaz Meltzer & Check, LLP is currently investigating potential violations of the federal securities laws on behalf of investors of Laboratory Corporation of America Holdings (NYSE: LH) (“Labcorp”). Labcorp is an...
Jan 06, 2022 11:00 am ET
(LH): Did You Lose Money on Your Laboratory Corp Stock? Contact Johnson Fistel Regarding Investigation
Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of the federal securities laws by Laboratory Corporation of America Holdings (“Labcorp” or the “Company”) (NYSE: LH). On January 1, 2022, New York Times released...
Jan 05, 2022 06:18 pm ET
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Laboratory Corporation of America Holdings (LH) on Behalf of Investors
Law Offices of Howard G. Smith announces an investigation on behalf of Laboratory Corporation of America Holdings (“Labcorp” or the “Company”) (NYSE: LH) investors concerning the Company’s possible violations of the federal securities laws.
Jan 04, 2022 04:29 pm ET
Labcorp to Speak Virtually at the 40th Annual J.P. Morgan Healthcare Conference
Labcorp (NYSE: LH), a leading global life sciences company, today announced that members of the executive management team will participate in a virtual fireside chat at the 40th Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 11 at 4:30 p.m. (ET).
Dec 23, 2021 07:09 am ET
Labcorp Strengthens Oncology Leadership Position With the Addition of Personal Genome Diagnostics, a Provider of Comprehensive Liquid Biopsy and Tissue-Based Genomic Products and Services
Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has entered into a definitive agreement to acquire Personal Genome Diagnostics Inc. (
Dec 09, 2021 06:58 am ET
Labcorp Announces Initiatives to Enhance Shareholder Value
Labcorp (NYSE: LH) (the Company), a leading global life sciences company, today announced actions that its Board of Directors (the Board) and management team have taken to enhance shareholder returns. This includes:
Dec 03, 2021 12:34 pm ET
Labcorp Completes Acquisition of Toxikon Corporation
Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has closed its acquisition of Toxikon Corporation, a contract research organization delivering best-in-class nonclinical testing services. The addition of Toxikon to Labcorp Drug Development bolsters Labcorp’s strong nonclinical development portfolio, and creates a strategic fo
Dec 01, 2021 07:21 am ET
Labcorp and ConcertAI Optimize Precision Oncology Research With Real-World Data and Artificial Intelligence
Labcorp (NYSE: LH), a leading global life sciences company, and ConcertAI, LLC (ConcertAI), a leader in enterprise artifici
Nov 30, 2021 07:03 am ET
Labcorp Now Offers Observed Collection for COVID-19 PCR Testing in Over 500 Locations Nationwide, With Plans to Expand to More Than 1,000 Locations
Labcorp (NYSE: LH), a global life sciences company, is now offering observed self-collection for COVID-19 PCR testing in more than 500 of its patient service centers (PSCs) nationwide for people without symptoms or known exposure. By mid-December, the company plans to further expand the COVID-19 PCR test collection service to over 1,000 locations.
Nov 18, 2021 07:09 am ET
Labcorp to Acquire Toxikon, Expanding Nonclinical Development Testing Capabilities for Pharmaceutical, Biotech and Medical Device Clients
Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has entered into a definitive agreement to acquire
Nov 04, 2021 05:57 pm ET
Labcorp and National Kidney Foundation Promote Patient Registry to Enhance Clinical Trial Accessibility, Diversity
Labcorp (NYSE: LH), a leading global life sciences company, and the National Kidney Foundation (NKF), the largest patient organization dedicated to the prevention and treatment of kidney disease, announced their collaboration to promote the
Nov 02, 2021 04:36 pm ET
Labcorp to Speak at Credit Suisse 30th Annual Healthcare Conference
Labcorp (NYSE: LH), a leading global life sciences company, today announced that members of its executive management team will participate in a virtual fireside chat at the Credit Suisse 30th Annual Healthcare Conference on Tuesday, Nov. 9 at 1:00 p.m. ET.
Nov 02, 2021 09:00 am ET
City of Boston and Ovia Health Launch Programs to Improve Maternal Health Outcomes
Ovia Health™, the only clinically-backed digital family health platform, announced today that it has partnered with the City of Boston, in collaboration with Blue Cross Blue Shield Massachusetts, to bring a suite of innovative and comprehensive...
Nov 01, 2021 10:01 am ET
Dr. Marcia Eisenberg, Labcorp Diagnostics Chief Scientific Officer, Named to Fierce Healthcare’s 2021 Women of Influence
Labcorp (NYSE: LH), a leading global life sciences company, today announced that Marcia Eisenberg, Ph.D., chief scientific officer of Labcorp Diagnostics, was recognized by Fierce Healthcare as one of its “
Oct 28, 2021 06:59 am ET
Labcorp Announces 2021 Third Quarter Results
Labcorp (NYSE: LH), a leading life sciences company, today announced results for the third quarter ended September 30, 2021, and raised full-year guidance.
Oct 01, 2021 10:12 am ET
Labcorp Receives Emergency Use Authorization for At Home Collection Kit for Combined COVID-19 and Flu Detection
Labcorp (NYSE: LH), a leading global life sciences company, today announced that it received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for a combined home collection kit that detects COVID-19 and influenza A/B simultaneously in individuals as young as 2 years of age. The kit will be available at no upfront cost to those who meet clinical guidelines, which may include experiencing symptoms, being exposed to someone with COVID-19 or if asked to be tested by a health care provider.
Sep 28, 2021 04:18 pm ET
Labcorp to Announce Third Quarter Financial Results on October 28, 2021
Labcorp (NYSE: LH), a leading global life sciences company, will release its financial results for the third quarter of 2021 before the market opens on Thursday, October 28, 2021. The company will host a conference call and webcast beginning at 9 a.m. ET that day to discuss the results. The earnings release and accompanying financial information will be posted on the
Sep 13, 2021 04:35 pm ET
Labcorp Completes Acquisition of Myriad Autoimmune’s Vectra Testing Business
Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has closed its acquisition of select operating assets and intellectual property (IP) from Myriad Genetics’ autoimmune business unit, including the Vectra® rheumatoid arthritis (RA) assay.
Sep 08, 2021 04:12 pm ET
Labcorp to Speak at Morgan Stanley 19th Annual Global Healthcare Conference
Labcorp (NYSE: LH), a leading global life sciences company, today announced that members of its executive management team will participate in a virtual fireside chat at the Morgan Stanley 19th Annual Global Healthcare Conference on Monday, Sept. 13 at 3:30 p.m. ET.
Sep 02, 2021 04:33 pm ET
Labcorp Raises Minimum Hourly Wage to $15 Per Hour
Labcorp (NYSE: LH), a leading global life sciences company, today announced it has increased the minimum hourly wage for United States (U.S.)-based, non-union employees to $15, effective September 2021.
Aug 19, 2021 04:37 pm ET
Labcorp and Community Clinical Oncology Research Network Collaborate to Assess Social and Economic Impacts of Disparities in Cancer Care
Labcorp (NYSE: LH), a leading global life sciences company, and Community Clinical Oncology Research Network, LLC (CCORN), a leading research organization, today announced their collaboration to better understand the impact of disparities in precision medicine for people with cancer. Information gathered from a patient registry and biobank will be used to help design future cancer clinical trials in diverse populations.
Aug 12, 2021 04:19 pm ET
Labcorp Extends Leadership in Women’s Health With Acquisition of Ovia Health
Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has acquired Ovia Health, a digital health platform used by millions of women seeking information and support with family planning, pregnancy and parenting.
Aug 05, 2021 07:15 am ET
National Kidney Foundation and Labcorp Data Show Millions Aren't Tested for Kidney Disease
NEW YORK, Aug. 5, 2021 /PRNewswire/ -- New data suggest that millions of patients most at-risk for life-threatening kidney disease are unaware they have it because they are not tested according to clinical practice guidelines despite their risk. The study, by authors from the National Kidney Foundation (NKF) and Labcorp, appears today in the journal Diabetes Care.
Jul 29, 2021 07:01 am ET
Labcorp Announces 2021 Second Quarter Results
Labcorp (NYSE: LH), a leading life sciences company, today announced results for the second quarter ended June 30, 2021, and raised full-year guidance.
Jul 02, 2021 06:59 am ET
Labcorp to Announce Second Quarter Financial Results on July 29, 2021
Labcorp (NYSE: LH), a leading global life sciences company, will release its financial results for the second quarter of 2021 before the market opens on Thursday, July 29, 2021. The company will host a conference call and webcast beginning at 9 a.m. ET that day to discuss the results. The earnings release and accompanying financial information will be posted on the
Jul 01, 2021 05:03 pm ET
Labcorp Launches Companion Diagnostic for Amgen’s Newly-approved Lung Cancer Therapy
Labcorp® (NYSE: LH), a leading global life sciences company, today announced the availability of therascreen® KRAS PCR Mutation Analysis, a companion diagnostic to identify patients with non-small cell lung cancer (NSCLC) who are eligible for treatment with LUMAKRAS™ (sotorasib), a new treatment option developed by Amgen.
Jun 22, 2021 08:28 am ET
Labcorp Adopts Molecular Loop SARS-CoV-2 Research Sequencing Panel for Large-Scale Viral Surveillance
NEWTON, Mass., June 22, 2021 /PRNewswire/ -- Molecular Loop Biosciences, Inc. , a company redefining the simplicity of targeted sequencing, announced today that its SARS-CoV-2 Research Sequencing Panel has been deployed by Labcorp (NYSE: LH), a leading global life sciences company, to help sequence thousands of complete coronavirus genomes each week from positive patient samples. This sequencing is being performed as part of a U.S. Centers for Disease Control and Prevention (CDC) effort to identify and track the spread of SARS-CoV-2 variants throughout the country.
Jun 14, 2021 11:11 am ET
Labcorp And OmniSeq Launch INSIGHT℠, Next-Generation Sequencing Platform to Advance Precision Oncology
BUFFALO, N.Y., June 14, 2021 /PRNewswire/ -- Labcorp (NYSE: LH), a leading global life sciences company, and OmniSeq, a CAP-accredited, molecular diagnostic innovation of Roswell Park Comprehensive Cancer Center, today announced the launch of OmniSeq INSIGHT℠, a comprehensive genomic and immune profiling, tissue-based test that integrates next-generation sequencing (NGS) technology. The test is designed to advance precision oncology and improve patient outcomes, as part of Labcorp's commitment to empower better health decisions for patients through the addition of cutting-edge diagnostic too
Jun 08, 2021 04:35 pm ET
Pixel by Labcorp® COVID-19 PCR Test Home Collection Kits Now Available Nationwide at Walgreens and Through On-Demand Delivery
Labcorp (NYSE: LH), a leading global life sciences company today announced that Pixel by Labcorp® COVID-19 PCR Test Home Collection Kits are now in 6,000 Walgreens stores nationwide and through Walgreens collaborations with on-demand delivery services DoorDash and Instacart. The newly expanded availability and delivery option advances Wa
Jun 02, 2021 05:20 pm ET
Labcorp to Introduce Combined Oncology Offering at 2021 ASCO® Annual Meeting
Labcorp (NYSE: LH), a leading global life sciences company, today announced the introduction of its combined Labcorp oncology platform at the virtual 2021 American Society of Clinical Oncology (ASCO®) Annual Meeting held June 4-8.
May 24, 2021 05:14 pm ET
Labcorp Study Suggests COVID-19 Antibodies Remain at Least 10 Months After Infection
Nearly 87% of naturally infected COVID-19 patients maintained antibodies to SARS-CoV-2 proteins for at least 10 months, according to a new Labcorp (NYSE: LH) analysis of specimens from 39,086 individuals.
May 19, 2021 05:54 pm ET
Labcorp to Expand Bioanalytical Services With Integrated Laboratory in Singapore
Labcorp (NYSE: LH), a leading global life sciences company, today announced the expansion of its drug development offering in the Asia-Pacific region with the addition of bioanalytical services in Singapore.
May 18, 2021 06:59 am ET
Labcorp to Speak at UBS Global Healthcare Virtual Conference
Labcorp (NYSE: LH), a leading global life sciences company, today announced that members of the executive management team will participate in a virtual fireside chat at the UBS Global Healthcare Virtual Conference on Monday, May 24 at 3:00 p.m. ET.
May 13, 2021 08:57 am ET
Pixel by Labcorp COVID-19 PCR Test Home Collection Kit Receives FDA Emergency Authorization for Ages 2-17
Labcorp (NYSE: LH), a leading global life sciences company, today announced that the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for its Pixel by Labcorp COVID-19 PCR Test Home Collection Kit for ages 2-17. The authorization expands the use of Pixel by Labcorp to children and adolescents 2 years of age and older when purchased by a parent or guardian.
May 12, 2021 08:14 pm ET
Labcorp Prices $500,000,000 in 1.550% Senior Notes Due 2026 and $500,000,000 in 2.700% Senior Notes Due 2031
Labcorp (NYSE: LH) (“Labcorp”) announced today that it has priced its offering of $1,000,000,000 in senior notes. The offering consists of two tranches: $500,000,000 aggregate principal amount of 1.550% Senior Notes due 2026 (the “2026 Notes”) and $500,000,000 aggregate principal amount of 2.700% Senior Notes due 2031 (the “2031 Notes” and, together with the 2026 Notes, the “Notes”). The Notes will bear interest from May 26, 2021, payable semi-annually on June 1 and December 1, commencing on December 1, 2021. The closing of the offering is expected to occur on May 26, 2021, subject to the sati
May 12, 2021 06:57 am ET
Labcorp Announces Proposed Sale of Senior Notes
Labcorp (NYSE: LH) (“Labcorp”) announced today that it plans to offer, subject to market and other conditions, senior notes that are expected to be issued in two tranches (the “Notes”). The Notes will be senior unsecured obligations and will rank equally with Labcorp’s existing and future senior unsecured debt.
May 11, 2021 04:18 pm ET
Labcorp and the U.S. Department of Health and Human Services Join Forces to Raise Awareness of COVID-19 Treatments
Labcorp (NYSE: LH), a leading global life sciences company, is working with the U.S. Department of Health and Human Services (HHS) to raise awareness of potentially lifesaving monoclonal antibody COVID-19 therapies.
May 03, 2021 04:05 pm ET
Myriad Genetics Delivers 12% Sequential Revenue Growth in March 2021 Quarter, Company Executes on Strategic Transformation Initiatives
Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced financial results for its quarter ended March 31, 2021 and provided an update on recent business performance.            Financial...
May 03, 2021 06:58 am ET
Labcorp to Acquire Myriad Autoimmune’s Vectra Testing Business From Myriad Genetics
Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has entered into a definitive agreement to acquire select operating assets and intellectual property (IP) from Myriad Genetics’ autoimmune business unit, including the Vectra® rheumatoid arthritis (RA) assay. More than one million Vectra tests have been completed since the product’s launch in November 2010, and a meaningful portion of testing volume currently flows through Labcorp.
Apr 29, 2021 06:56 am ET
Labcorp Announces 2021 First Quarter Results
Labcorp (NYSE: LH), a leading life sciences company, today announced results for the first quarter ended March 31, 2021 and raised 2021 guidance.
Apr 20, 2021 04:13 pm ET
Labcorp Launches COVID-19 Test Kits for Small Businesses to Support Return to Work and Life Safely
Labcorp (NYSE: LH), a leading global life sciences company, today announced the availability of the Pixel by Labcorp® COVID-19 PCR Test Home Collection Kit for small businesses, an initiative aimed at providing fast, convenient, and reliable testing for companies with as many as 120 employees. Labcorp Employer Services currently provide
Apr 16, 2021 07:01 am ET
Labcorp to Webcast Its Annual Meeting of Shareholders
Labcorp (NYSE: LH), a leading global life sciences company, today announced that its Annual Meeting of Shareholders will be webcast live beginning May 12, at 9:00 a.m. ET via the company website at www.Labcorp.com. An archived replay of the webcast will be available for one year.
Mar 30, 2021 04:30 pm ET
Labcorp to Announce First Quarter Financial Results on April 29, 2021
Labcorp (NYSE: LH), a leading global life sciences company, will release its first quarter of 2021 financial results before the market opens on Thursday, April 29, 2021, and then will host a conference call and webcast beginning at 9:00 a.m. ET to discuss the results. The earnings release and accompanying financial information will be posted on the
Mar 26, 2021 06:57 am ET
Labcorp Appoints Johnson & Johnson Executive Kathryn Wengel to the Board of Directors
Labcorp (NYSE: LH), a leading global life sciences company, today announced the appointment of Kathryn Wengel, current Executive Vice President and Chief Global Supply Chain Officer at Johnson & Johnson, as an independent member of Labcorp’s Board of Directors, effective immediately. In connection with this appointment, the Labcorp Board will expand from 9 to 10 directors.
Mar 25, 2021 06:59 am ET
Labcorp Lays out Priorities and Progress in Corporate Responsibility Report
Labcorp (NYSE: LH), a leading global life sciences company, today issued its 2019-2020 Corporate Responsibility Report: Making a Difference When It Counts. The report includes the ways in which Labcorp carries out its mission of improving health and improving lives, and charts it
Mar 23, 2021 05:00 pm ET
Labcorp Business Update
Labcorp (NYSE: LH), a leading life sciences company, today issued the following statement:
Mar 23, 2021 11:02 am ET
Dr. Marcia Eisenberg, Chief Scientific Officer of Labcorp Diagnostics, Named a Healthcare Businesswoman’s Association Luminary
Labcorp (NYSE: LH), a leading global life sciences company, today announced that Marcia Eisenberg, Ph.D., chief scientific officer of Labcorp Diagnostics, was recognized by the Healthcare Businesswomen’s Association (HBA) as a 2021 Luminary. This title honors the 30-plus years of Dr. Eisenberg’s career, which she has dedicated to innovations in healthcare and science, as well as her efforts in the advancement of women in the industry.
Mar 19, 2021 06:58 am ET
Labcorp Scheduled to Speak at KeyBanc Capital Markets' Life Sciences and MedTech Investor Forum
Labcorp (NYSE: LH), a leading global life sciences company, today announced that members of the executive management team will participate in a virtual fireside chat at KeyBanc Capital Markets' Life Sciences and MedTech Investor Forum on Wednesday, March 24 at 2:00 p.m. ET.
Mar 09, 2021 07:34 am ET
Labcorp Named to Fast Company’s List of the World’s Most Innovative Companies for 2021
Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has been named to Fast Company magazine’s list of 2021 Most Innovative Companies. Since 2008, the annual list has been the definitive source for recognizing the organizations that are transforming industries and shaping society.
Feb 24, 2021 01:00 pm ET
Walgreens to Make Pixel by Labcorp™ COVID-19 PCR Test Home Collection Kit Available Over-The-Counter at Stores Nationwide
As part of Walgreens ongoing efforts to increase access to COVID-19 testing in communities across the U.S., the company announced today it has entered into an agreement with Labcorp™ to sell Pixel by Labcorp COVID-19 PCR Test Home Collection Kits over-the-counter in up to 6,000 Walgreens stores nationwide beginning in spring of this year. Walgreens
Feb 23, 2021 09:15 am ET
Adaptive Biotechnologies Expands Collaboration with Labcorp to Increase Access to Growing Research and Clinical Diagnostic Portfolio
Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced an expansion of...
Feb 23, 2021 06:54 am ET
Labcorp is Scheduled to Speak at Citi's 2021 Healthcare Services, Medtech, Tools, & HCIT Virtual Conference
Labcorp (NYSE: LH), a leading global life sciences company, today announced that members of the executive management team will participate in a virtual fireside chat at Citi's 2021 Healthcare Services, Medtech, Tools, & HCIT Virtual Conference on Thursday, Feb. 25 at 1:30 p.m. ET.
Feb 18, 2021 08:01 am ET
Pacific Biosciences Sequel II Systems Deployed to Scale-Up Global Viral Surveillance Initiatives Focused on COVID-19
Pacific Biosciences of California, Inc. (Nasdaq: PACB), a leading provider of high-quality, long-read sequencing platforms, today announced that Labcorp (NYSE: LH), a leading global life sciences company, has increased its commitment to highly...
Feb 17, 2021 06:57 am ET
Labcorp Adds High Sensitivity Antigen Test to Screen for Active COVID-19 Infection
Labcorp (NYSE: LH), a leading global life sciences company, today announced the availability of a new laboratory-based antigen test that will help doctors determine if an individual is actively infected with COVID-19.
Feb 16, 2021 12:59 pm ET
Amy Summy, Chief Marketing Officer of Labcorp, Named to Forbes’ CMO Next
Labcorp (NYSE: LH), a leading global life sciences company, today announced that Amy Summy, executive vice president and chief marketing officer, was recognized on the 2021 Forbes CMO Next list for her leadership during the COVID-19 crisis, while also spearheading the rebranding strategy that highlighted the power of Labcorp’s combined diagnostic and drug development businesses. Forbes also recognized Amy’s work in launching several products, including the company’s Pixel by Labcorp™ at-home testing kits.
Feb 11, 2021 06:58 am ET
Labcorp Announces 2020 Fourth Quarter and Full Year Results and Provides 2021 Guidance
Labcorp (NYSE: LH), a leading life sciences company, today announced results for the fourth quarter and year ended December 31, 2020, and full year 2021 guidance.
Feb 09, 2021 11:02 am ET
Labcorp Announces Key Appointments to Oncology Leadership Team
Labcorp (NYSE: LH), a leading global life sciences company, today announced the appointments of Prasanth Reddy, MD, MPH, and Robert Phillips, PhD, to its oncology team, advancing Labcorp’s leadership position and capabilities in cancer diagnosis, treatment, and drug development.
Feb 01, 2021 03:39 pm ET
Labcorp Named to FORTUNE® Magazine’s 2021 ‘World’s Most Admired Companies,’ Making the Annual List for the Third Time
Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has been named to FORTUNE® magazine's 2021 List of World’s Most Admired Companies, making the annual list for the third time. The annual survey, conducted by FORTUNE and Korn Ferry, a global organizational consulting firm, is given to top executives, directors, and financial analysts to identify the companies that enjoy the strongest reputations within their industries and across industries.
Jan 28, 2021 11:28 am ET
Labcorp Earns 100 Percent on Human Rights Campaign Foundation’s Annual Scorecard on LGBTQ Workplace Equality
Labcorp® (NYSE: LH), a leading global life sciences company, today announced that it received a perfect score of 100 percent on the Human Rights Campaign Foundation’s 2021 Corporate Equality Index (CEI), the nation’s premier benchmarking surv
Jan 19, 2021 07:00 am ET
Labcorp Appoints Dr. Deborah Ann Sesok-Pizzini as Chief Medical Officer, Labcorp Diagnostics
Labcorp, (NYSE: LH), a leading global life sciences company, announced today that Dr. Deborah Ann Sesok-Pizzini has been appointed Chief Medical Officer of Labcorp Diagnostics, following the retirement of Dr. Dot Adcock in April 2021. Dr. Sesok-Pizzini assumed the role starting on January 11, 2021.
Jan 08, 2021 06:57 am ET
Labcorp to Announce Fourth Quarter and Full Year 2020 Financial Results on February 11, 2021
Labcorp (NYSE: LH), a leading global life sciences company, will release its fourth quarter and full year 2020 financial results before the market opens on Thursday, Feb. 11, 2021, and then will host a conference call and webcast beginning at 9:00 a.m. ET to discuss the results. The earnings release and accompanying financial information will be posted on the
Jan 07, 2021 04:20 pm ET
Labcorp Awarded CDC Contract to Study Variants of COVID-19 Virus and Improve Public Health Response
Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has been awarded a contract from the Centers for Disease Control and Prevention (CDC) to provide genomic sequencing of samples of SARS-CoV-2, the virus that causes COVID-19.
Jan 06, 2021 07:40 am ET
Brian Caveney, Chief Medical Officer and President of Labcorp Diagnostics, Named to Modern Healthcare's 100 Most Influential People in Healthcare
Labcorp (NYSE: LH), a leading global life sciences company, today announced that Dr. Brian Caveney, chief medical officer and president of Labcorp Diagnostics, was recognized by Modern Healthcare as one of the 100 most influential people in healthcare in 2020.
Jan 05, 2021 06:59 am ET
Labcorp Is Scheduled to Virtually Participate at the 39th Annual J.P. Morgan Healthcare Conference
Labcorp (NYSE: LH), a leading global life sciences company, today announced that members of the executive management team will participate in a virtual fireside chat at the 39th Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 12 at 8:20 a.m. (EST).
Dec 21, 2020 06:57 am ET
Walgreens and Labcorp Make Pixel by Labcorp™ At-Home COVID-19 Collection Kit Available Through Walgreens Find Care®
Labcorp (NYSE: LH), a leading global life sciences company that is focused on advancing health and guiding patient care decisions, and Walgreens today announced that the Pixel by Labcorp™ At-Home COVID-19 Collection Kit is now available from Labcorp through Walgreens Find Care®, a digital health platfor
Dec 09, 2020 05:57 pm ET
LabCorp Receives FDA Authorization to Make At-Home COVID-19 Collection Kits Available Through Retail
LabCorp (NYSE: LH), a leading global life sciences company that is focused on advancing health and guiding patient care decisions, today announced that the U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) for the Pixel by LabCorp™ COVID-19 Test Home Collection Kit to become the first to be available over the counter without requiring a prescription. The kit is currently available through the
Nov 25, 2020 06:56 am ET
LabCorp Is Scheduled to Present at The 2020 Evercore ISI 3rd Annual HealthCONx Conference
LabCorp (NYSE: LH), a leading global life sciences company that is focused on advancing health and guiding patient care decisions, today announced that members of the executive management team will participate in a virtual fireside chat at the 3rd Annual Evercore ISI HealthCONx Conference on Thursday, Dec. 3 at 1:50 p.m. ET.
Nov 20, 2020 07:55 am ET
Circuit Clinical®, LabCorp, and Riverside Medical Group Collaborate to Expand Clinical Trial Access in New Jersey
BUFFALO, N.Y., BURLINGTON, N.C., and SECAUCUS, N.J., Nov. 20, 2020 /PRNewswire/ -- Circuit Clinical®, a network of physicians and clinical research professionals devoted to and passionate about bringing clinical research to everyone; Riverside Medical Group (RMG), a leading regional medical practice in New Jersey; and LabCorp, (NYSE: LH), a leading global life sciences company, today announced a multi-faceted collaboration that will enable RMG's patients to participate in clinical trials of new treatments and therapies within their own doctor's office.
Nov 17, 2020 07:00 am ET
Leading Diagnostics Companies Join Forces to Establish the Access to Comprehensive Genomic Profiling Coalition (ACGP)
WASHINGTON, Nov. 17, 2020 /PRNewswire/ -- Seven leading diagnostics companies and laboratory service providers have formed the Access to Comprehensive Genomic Profiling Coalition (ACGP). The goal of the organization is to collectively advocate for appropriate broad U.S. health insurance coverage of comprehensive genomic profiling (CGP) for patients living with advanced cancer. The current members of ACGP are Exact Sciences (NASDAQ: EXAS), Foundation Medicine, Illumina (NASDAQ: ILMN), LabCorp (NYSE: LH), QIAGEN (NYSE: QGEN), Roche Diagnostics (SIX: RO, ROG: OTCQX: RHHBY), and Thermo Fisher Sc
Nov 02, 2020 06:58 am ET
LabCorp Is Scheduled to Present at the 29th Annual Credit Suisse Virtual Healthcare Conference
LabCorp (NYSE: LH) today announced that members of the executive management team will participate in a virtual fireside chat at the 29th Annual Credit Suisse Virtual Healthcare Conference on Monday, Nov. 9 at 8:00 a.m. ET.

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.